Novel motif:148: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif148_NTCSYSTYT
|novel_motifs_human_sample_pval=11376-118A8_11051;0.912709,11327-117E4_11969;0.756882,11473-119C6_11054;0.930414,11474-119C7_12067;0.7...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:20, 9 September 2013
name: | motif148_NTCSYSTYT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0070863 | positive regulation of protein exit from endoplasmic reticulum | 1.721376e-10 |
GO:0051497 | negative regulation of stress fiber assembly | 2.823998e-8 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 3.143627e-8 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 5.962883e-8 |
GO:0008050 | female courtship behavior | 9.903496e-8 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.561163e-7 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.696438e-7 |
GO:0035306 | positive regulation of dephosphorylation | 1.877413e-7 |
GO:0007619 | courtship behavior | 2.747440e-7 |
GO:0006337 | nucleosome disassembly | 4.556178e-7 |
GO:0001732 | formation of translation initiation complex | 5.154787e-7 |
GO:0015798 | myo-inositol transport | 6.507069e-7 |
GO:0009404 | toxin metabolic process | 6.704826e-7 |
GO:0035304 | regulation of protein dephosphorylation | 7.276440e-7 |
GO:0032232 | negative regulation of actin filament bundle assembly | 7.886644e-7 |
GO:0015791 | polyol transport | 1.236465e-6 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 2.027148e-6 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 2.229085e-6 |
GO:0007621 | negative regulation of female receptivity | 2.641530e-6 |
GO:0033057 | multicellular organismal reproductive behavior | 3.995242e-6 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 5.537966e-6 |
GO:0045924 | regulation of female receptivity | 5.976730e-6 |
GO:0090251 | protein localization involved in establishment of planar polarity | 7.328472e-6 |
GO:0001764 | neuron migration | 9.327624e-6 |
GO:0006680 | glucosylceramide catabolic process | 1.250044e-5 |
GO:0030421 | defecation | 1.250044e-5 |
GO:0048203 | vesicle targeting, trans-Golgi to endosome | 1.470579e-5 |
GO:0015850 | organic alcohol transport | 1.572665e-5 |
GO:0002921 | negative regulation of humoral immune response | 2.184600e-5 |
GO:0002707 | negative regulation of lymphocyte mediated immunity | 2.480741e-5 |
GO:0033561 | regulation of water loss via skin | 2.646862e-5 |
GO:0015747 | urate transport | 2.646862e-5 |
GO:0016255 | attachment of GPI anchor to protein | 2.842157e-5 |
GO:0060490 | lateral sprouting involved in lung morphogenesis | 3.025128e-5 |
GO:0060489 | planar dichotomous subdivision of terminal units involved in lung branching morphogenesis | 3.025128e-5 |
GO:0048105 | establishment of body hair planar orientation | 3.025128e-5 |
GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis | 3.025128e-5 |
GO:0032092 | positive regulation of protein binding | 3.061681e-5 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 3.361866e-5 |
GO:0035024 | negative regulation of Rho protein signal transduction | 3.609068e-5 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 4.015110e-5 |
GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.497816e-5 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 4.733410e-5 |
GO:0042696 | menarche | 4.942853e-5 |
GO:0050856 | regulation of T cell receptor signaling pathway | 4.992251e-5 |
GO:0030900 | forebrain development | 5.090883e-5 |
GO:0007617 | mating behavior | 5.159204e-5 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 5.424748e-5 |
GO:0021871 | forebrain regionalization | 5.685487e-5 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 6.114049e-5 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 6.725580e-5 |
GO:0060318 | definitive erythrocyte differentiation | 6.873426e-5 |
GO:0051156 | glucose 6-phosphate metabolic process | 7.711487e-5 |
GO:0060347 | heart trabecula formation | 9.639113e-5 |
GO:0060972 | left/right pattern formation | 9.880832e-5 |
GO:0050891 | multicellular organismal water homeostasis | 9.975269e-5 |
GO:0035378 | carbon dioxide transmembrane transport | 1.004608e-4 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 1.004608e-4 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 1.004608e-4 |
GO:0035377 | transepithelial water transport | 1.004608e-4 |
GO:0043407 | negative regulation of MAP kinase activity | 1.139760e-4 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 1.242309e-4 |
GO:0032747 | positive regulation of interleukin-23 production | 1.343791e-4 |
GO:0061384 | heart trabecular morphogenesis | 1.345156e-4 |
GO:0007417 | central nervous system development | 1.358032e-4 |
GO:0048041 | focal adhesion assembly | 1.368538e-4 |
GO:0030719 | P granule organization | 1.451340e-4 |
GO:0023021 | termination of signal transduction | 1.465078e-4 |
GO:0021759 | globus pallidus development | 1.465078e-4 |
GO:0006686 | sphingomyelin biosynthetic process | 1.477108e-4 |
GO:0002820 | negative regulation of adaptive immune response | 1.733245e-4 |
GO:0009651 | response to salt stress | 2.011695e-4 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 2.030298e-4 |
GO:0042267 | natural killer cell mediated cytotoxicity | 2.220512e-4 |
GO:0003105 | negative regulation of glomerular filtration | 2.335285e-4 |
GO:0001561 | fatty acid alpha-oxidation | 2.355139e-4 |
GO:0045577 | regulation of B cell differentiation | 2.373619e-4 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 2.387301e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.540991e-4 |
GO:0035413 | positive regulation of catenin import into nucleus | 2.694146e-4 |
GO:0090316 | positive regulation of intracellular protein transport | 2.878051e-4 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 2.988865e-4 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 3.041942e-4 |
GO:0030213 | hyaluronan biosynthetic process | 3.083064e-4 |
GO:0060968 | regulation of gene silencing | 3.096932e-4 |
GO:0042107 | cytokine metabolic process | 3.172834e-4 |
GO:0046513 | ceramide biosynthetic process | 3.236234e-4 |
GO:0010963 | regulation of L-arginine import | 3.508432e-4 |
GO:0046512 | sphingosine biosynthetic process | 3.606596e-4 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 3.716114e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4.036124e-4 |
GO:0032388 | positive regulation of intracellular transport | 4.057043e-4 |
GO:0007403 | glial cell fate determination | 4.107725e-4 |
GO:0019098 | reproductive behavior | 4.484608e-4 |
GO:0060492 | lung induction | 4.656643e-4 |
GO:0007256 | activation of JNKK activity | 5.241118e-4 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 5.575144e-4 |
GO:0042089 | cytokine biosynthetic process | 5.575684e-4 |
GO:0019242 | methylglyoxal biosynthetic process | 5.582213e-4 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 5.731622e-4 |
GO:0071843 | cellular component biogenesis at cellular level | 5.879989e-4 |
GO:0032320 | positive regulation of Ras GTPase activity | 5.912134e-4 |
GO:0060051 | negative regulation of protein glycosylation | 6.199724e-4 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 6.212523e-4 |
GO:0042538 | hyperosmotic salinity response | 6.254599e-4 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 6.254599e-4 |
GO:0006281 | DNA repair | 6.271736e-4 |
GO:0001909 | leukocyte mediated cytotoxicity | 6.428830e-4 |
GO:0051492 | regulation of stress fiber assembly | 6.457431e-4 |
GO:0022618 | ribonucleoprotein complex assembly | 6.539994e-4 |
GO:0060448 | dichotomous subdivision of terminal units involved in lung branching | 6.615420e-4 |
GO:0006383 | transcription from RNA polymerase III promoter | 6.768921e-4 |
GO:0009438 | methylglyoxal metabolic process | 6.859173e-4 |
GO:0001835 | blastocyst hatching | 7.380853e-4 |
GO:0006396 | RNA processing | 7.762938e-4 |
GO:0045351 | type I interferon biosynthetic process | 7.786106e-4 |
GO:0060317 | cardiac epithelial to mesenchymal transition | 7.809982e-4 |
GO:0046520 | sphingoid biosynthetic process | 7.903528e-4 |
GO:0008360 | regulation of cell shape | 7.905894e-4 |
GO:0007420 | brain development | 7.971572e-4 |
GO:0014745 | negative regulation of muscle adaptation | 8.206813e-4 |
GO:0033261 | regulation of S phase | 8.240472e-4 |
GO:0071549 | cellular response to dexamethasone stimulus | 8.325277e-4 |
GO:0021987 | cerebral cortex development | 8.556747e-4 |
GO:0035148 | tube formation | 9.078284e-4 |
GO:0071280 | cellular response to copper ion | 9.100160e-4 |
GO:0006972 | hyperosmotic response | 9.338019e-4 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 9.355916e-4 |
GO:0050434 | positive regulation of viral transcription | 9.439097e-4 |
GO:0035303 | regulation of dephosphorylation | 9.861018e-4 |
GO:0060049 | regulation of protein glycosylation | 9.938259e-4 |
GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep | 9.938259e-4 |
GO:0071826 | ribonucleoprotein complex subunit organization | 1.000490e-3 |
GO:0032667 | regulation of interleukin-23 production | 1.005061e-3 |
GO:0006678 | glucosylceramide metabolic process | 1.055342e-3 |
GO:0071288 | cellular response to mercury ion | 1.082363e-3 |
GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness | 1.082363e-3 |
GO:0010664 | negative regulation of striated muscle cell apoptosis | 1.144610e-3 |
GO:2000008 | regulation of protein localization at cell surface | 1.161150e-3 |
GO:0016998 | cell wall macromolecule catabolic process | 1.197869e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.256954e-3 |
GO:0006353 | transcription termination, DNA-dependent | 1.292473e-3 |
GO:0032851 | positive regulation of Rab GTPase activity | 1.363015e-3 |
GO:0046878 | positive regulation of saliva secretion | 1.377327e-3 |
GO:0044036 | cell wall macromolecule metabolic process | 1.450343e-3 |
GO:0000245 | spliceosome assembly | 1.451082e-3 |
GO:0048240 | sperm capacitation | 1.659053e-3 |
GO:0048146 | positive regulation of fibroblast proliferation | 1.665606e-3 |
GO:0070986 | left/right axis specification | 1.718303e-3 |
GO:0046415 | urate metabolic process | 1.731199e-3 |
GO:0050853 | B cell receptor signaling pathway | 1.761681e-3 |
GO:0070664 | negative regulation of leukocyte proliferation | 1.785666e-3 |
GO:0071472 | cellular response to salt stress | 1.842608e-3 |
GO:0001826 | inner cell mass cell differentiation | 1.842608e-3 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 1.970908e-3 |
GO:0071474 | cellular hyperosmotic response | 1.972379e-3 |
GO:0002238 | response to molecule of fungal origin | 2.036084e-3 |
GO:0005977 | glycogen metabolic process | 2.064082e-3 |
GO:0007030 | Golgi organization | 2.073812e-3 |
GO:0042723 | thiamine-containing compound metabolic process | 2.118009e-3 |
GO:0001964 | startle response | 2.285901e-3 |
GO:0006073 | cellular glucan metabolic process | 2.295803e-3 |
GO:0003211 | cardiac ventricle formation | 2.321518e-3 |
GO:0090310 | negative regulation of methylation-dependent chromatin silencing | 2.395313e-3 |
GO:0046060 | dATP metabolic process | 2.395313e-3 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.456921e-3 |
GO:0032606 | type I interferon production | 2.468472e-3 |
GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 2.561933e-3 |
GO:0006397 | mRNA processing | 2.571489e-3 |
GO:0050672 | negative regulation of lymphocyte proliferation | 2.622086e-3 |
GO:0014066 | regulation of phosphatidylinositol 3-kinase cascade | 2.622086e-3 |
GO:0042130 | negative regulation of T cell proliferation | 2.658432e-3 |
GO:0001843 | neural tube closure | 2.798020e-3 |
GO:0072086 | specification of loop of Henle identity | 2.870317e-3 |
GO:0046877 | regulation of saliva secretion | 2.870317e-3 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 2.915488e-3 |
GO:0009798 | axis specification | 2.938326e-3 |
GO:0060606 | tube closure | 3.021098e-3 |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase cascade | 3.023973e-3 |
GO:0046184 | aldehyde biosynthetic process | 3.040569e-3 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 3.065815e-3 |
GO:0051414 | response to cortisol stimulus | 3.098100e-3 |
GO:0046477 | glycosylceramide catabolic process | 3.174117e-3 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 3.186921e-3 |
GO:0006386 | termination of RNA polymerase III transcription | 3.186921e-3 |
GO:0033326 | cerebrospinal fluid secretion | 3.216898e-3 |
GO:0015670 | carbon dioxide transport | 3.216898e-3 |
GO:0014020 | primary neural tube formation | 3.236554e-3 |
GO:0071824 | protein-DNA complex subunit organization | 3.378301e-3 |
GO:0006974 | response to DNA damage stimulus | 3.386288e-3 |
GO:0006346 | methylation-dependent chromatin silencing | 3.398484e-3 |
GO:0003357 | noradrenergic neuron differentiation | 3.420651e-3 |
GO:0071681 | cellular response to indole-3-methanol | 3.514606e-3 |
GO:0046185 | aldehyde catabolic process | 3.588054e-3 |
GO:0046782 | regulation of viral transcription | 3.683348e-3 |
GO:0032776 | DNA methylation on cytosine | 3.754874e-3 |
GO:0021527 | spinal cord association neuron differentiation | 3.767527e-3 |
GO:0031128 | developmental induction | 3.798709e-3 |
GO:0001838 | embryonic epithelial tube formation | 3.842325e-3 |
GO:0034644 | cellular response to UV | 4.063267e-3 |
GO:0021586 | pons maturation | 4.244117e-3 |
GO:0032231 | regulation of actin filament bundle assembly | 4.248140e-3 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 4.296078e-3 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 4.406148e-3 |
GO:0006302 | double-strand break repair | 4.435251e-3 |
GO:0008380 | RNA splicing | 4.499583e-3 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 4.541903e-3 |
GO:0019748 | secondary metabolic process | 4.644884e-3 |
GO:0072175 | epithelial tube formation | 4.710979e-3 |
GO:0060928 | atrioventricular node cell development | 4.756490e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 4.756490e-3 |
GO:0003342 | proepicardium development | 4.756490e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 4.756490e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 4.827063e-3 |
GO:0035239 | tube morphogenesis | 5.107301e-3 |
GO:0001841 | neural tube formation | 5.107372e-3 |
GO:0042420 | dopamine catabolic process | 5.123995e-3 |
GO:0042094 | interleukin-2 biosynthetic process | 5.123995e-3 |
GO:0003215 | cardiac right ventricle morphogenesis | 5.319653e-3 |
GO:0006684 | sphingomyelin metabolic process | 5.322114e-3 |
GO:0055014 | atrial cardiac muscle cell development | 5.328433e-3 |
GO:0021536 | diencephalon development | 5.385981e-3 |
GO:0035811 | negative regulation of urine volume | 5.575692e-3 |
GO:0050775 | positive regulation of dendrite morphogenesis | 5.610262e-3 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 5.707213e-3 |
GO:0007614 | short-term memory | 5.754020e-3 |
GO:0051402 | neuron apoptosis | 5.775175e-3 |
GO:0008355 | olfactory learning | 5.861983e-3 |
GO:0030157 | pancreatic juice secretion | 5.919211e-3 |
GO:0051567 | histone H3-K9 methylation | 6.090587e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 6.454452e-3 |
GO:0021761 | limbic system development | 6.510472e-3 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 6.606787e-3 |
GO:0072081 | specification of nephron tubule identity | 6.632960e-3 |
GO:0010662 | regulation of striated muscle cell apoptosis | 6.635563e-3 |
GO:0006044 | N-acetylglucosamine metabolic process | 6.635563e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 6.700389e-3 |
GO:0060134 | prepulse inhibition | 6.968005e-3 |
GO:0003166 | bundle of His development | 6.976854e-3 |
GO:0021575 | hindbrain morphogenesis | 7.572425e-3 |
GO:0045930 | negative regulation of mitotic cell cycle | 7.605336e-3 |
GO:0019395 | fatty acid oxidation | 7.672153e-3 |
GO:0005979 | regulation of glycogen biosynthetic process | 7.711538e-3 |
GO:0060971 | embryonic heart tube left/right pattern formation | 7.717227e-3 |
GO:0042048 | olfactory behavior | 7.717227e-3 |
GO:0060920 | pacemaker cell differentiation | 7.717227e-3 |
GO:0006701 | progesterone biosynthetic process | 7.801522e-3 |
GO:0030336 | negative regulation of cell migration | 7.834687e-3 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 8.111356e-3 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 8.111356e-3 |
GO:0007286 | spermatid development | 8.140061e-3 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 8.152266e-3 |
GO:0010656 | negative regulation of muscle cell apoptosis | 8.290391e-3 |
GO:0016331 | morphogenesis of embryonic epithelium | 8.310405e-3 |
GO:0071548 | response to dexamethasone stimulus | 8.418923e-3 |
GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep | 8.428342e-3 |
GO:0045176 | apical protein localization | 8.469320e-3 |
GO:0010225 | response to UV-C | 8.571111e-3 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 8.619322e-3 |
GO:0071108 | protein K48-linked deubiquitination | 8.957451e-3 |
GO:0042466 | chemokinesis | 9.081673e-3 |
GO:0060662 | salivary gland cavitation | 9.225339e-3 |
GO:0060765 | regulation of androgen receptor signaling pathway | 9.293442e-3 |
GO:0033327 | Leydig cell differentiation | 9.308040e-3 |
GO:0060430 | lung saccule development | 9.450423e-3 |
GO:0060441 | epithelial tube branching involved in lung morphogenesis | 9.535881e-3 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 9.679048e-3 |
GO:0048515 | spermatid differentiation | 9.744084e-3 |
GO:0007605 | sensory perception of sound | 9.750165e-3 |
GO:0003093 | regulation of glomerular filtration | 9.768472e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 9.810397e-3 |
GO:0034440 | lipid oxidation | 9.897859e-3 |
GO:0015872 | dopamine transport | 9.911232e-3 |
GO:0006670 | sphingosine metabolic process | 9.911232e-3 |
GO:0032508 | DNA duplex unwinding | 9.991252e-3 |
GO:0021795 | cerebral cortex cell migration | 1.007539e-2 |
GO:0032259 | methylation | 1.011007e-2 |
GO:0042045 | epithelial fluid transport | 1.012171e-2 |
GO:0080111 | DNA demethylation | 1.014700e-2 |
GO:0007028 | cytoplasm organization | 1.017116e-2 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.017116e-2 |
GO:0051851 | modification by host of symbiont morphology or physiology | 1.029031e-2 |
GO:0006304 | DNA modification | 1.054068e-2 |
GO:0060999 | positive regulation of dendritic spine development | 1.062935e-2 |
GO:0043620 | regulation of DNA-dependent transcription in response to stress | 1.067741e-2 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 1.078180e-2 |
GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | 1.085022e-2 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.086832e-2 |
GO:2000146 | negative regulation of cell motility | 1.094126e-2 |
GO:0046689 | response to mercury ion | 1.094128e-2 |
GO:0048524 | positive regulation of viral reproduction | 1.099287e-2 |
GO:0032494 | response to peptidoglycan | 1.110311e-2 |
GO:0042424 | catecholamine catabolic process | 1.112626e-2 |
GO:0030902 | hindbrain development | 1.113765e-2 |
GO:0051901 | positive regulation of mitochondrial depolarization | 1.122555e-2 |
GO:0009304 | tRNA transcription | 1.122555e-2 |
GO:0003219 | cardiac right ventricle formation | 1.122555e-2 |
GO:0032854 | positive regulation of Rap GTPase activity | 1.129736e-2 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 1.131353e-2 |
GO:0060486 | Clara cell differentiation | 1.138022e-2 |
GO:0032392 | DNA geometric change | 1.149297e-2 |
GO:0000730 | DNA recombinase assembly | 1.160830e-2 |
GO:0070873 | regulation of glycogen metabolic process | 1.178921e-2 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 1.201928e-2 |
GO:0008615 | pyridoxine biosynthetic process | 1.210565e-2 |
GO:0006501 | C-terminal protein lipidation | 1.211601e-2 |
GO:0003007 | heart morphogenesis | 1.219297e-2 |
GO:0046479 | glycosphingolipid catabolic process | 1.243322e-2 |
GO:0016579 | protein deubiquitination | 1.244310e-2 |
GO:0030104 | water homeostasis | 1.247771e-2 |
GO:0046514 | ceramide catabolic process | 1.270585e-2 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 1.280125e-2 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 1.292702e-2 |
GO:0071285 | cellular response to lithium ion | 1.297334e-2 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1.298226e-2 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 1.307309e-2 |
GO:0006470 | protein dephosphorylation | 1.319066e-2 |
GO:0022601 | menstrual cycle phase | 1.326248e-2 |
GO:0008654 | phospholipid biosynthetic process | 1.349045e-2 |
GO:0061072 | iris morphogenesis | 1.354652e-2 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.366122e-2 |
GO:0060179 | male mating behavior | 1.376032e-2 |
GO:0006863 | purine base transport | 1.383440e-2 |
GO:0035412 | regulation of catenin import into nucleus | 1.384564e-2 |
GO:0003209 | cardiac atrium morphogenesis | 1.398055e-2 |
GO:0021510 | spinal cord development | 1.405357e-2 |
GO:0010561 | negative regulation of glycoprotein biosynthetic process | 1.406169e-2 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 1.424853e-2 |
GO:0009062 | fatty acid catabolic process | 1.429646e-2 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.432455e-2 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 1.442173e-2 |
GO:0002920 | regulation of humoral immune response | 1.479611e-2 |
GO:0035520 | monoubiquitinated protein deubiquitination | 1.493971e-2 |
GO:0060135 | maternal process involved in female pregnancy | 1.514881e-2 |
GO:0034728 | nucleosome organization | 1.531028e-2 |
GO:0006419 | alanyl-tRNA aminoacylation | 1.550695e-2 |
GO:0007618 | mating | 1.555459e-2 |
GO:0031400 | negative regulation of protein modification process | 1.582185e-2 |
GO:0032318 | regulation of Ras GTPase activity | 1.597491e-2 |
GO:0006259 | DNA metabolic process | 1.611890e-2 |
GO:0060413 | atrial septum morphogenesis | 1.614740e-2 |
GO:0003097 | renal water transport | 1.631363e-2 |
GO:0061004 | pattern specification involved in kidney development | 1.678681e-2 |
GO:0034621 | cellular macromolecular complex subunit organization | 1.687522e-2 |
GO:0031629 | synaptic vesicle fusion to presynaptic membrane | 1.715532e-2 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.715699e-2 |
GO:0021516 | dorsal spinal cord development | 1.725224e-2 |
GO:0060124 | positive regulation of growth hormone secretion | 1.775607e-2 |
GO:0051271 | negative regulation of cellular component movement | 1.791738e-2 |
GO:0046521 | sphingoid catabolic process | 1.793303e-2 |
GO:0035510 | DNA dealkylation | 1.793303e-2 |
GO:0008105 | asymmetric protein localization | 1.794101e-2 |
GO:0034329 | cell junction assembly | 1.797967e-2 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 1.812282e-2 |
GO:0003230 | cardiac atrium development | 1.815430e-2 |
GO:0001825 | blastocyst formation | 1.826821e-2 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.829424e-2 |
GO:0071482 | cellular response to light stimulus | 1.834507e-2 |
GO:0001977 | renal system process involved in regulation of blood volume | 1.875589e-2 |
GO:0051099 | positive regulation of binding | 1.893071e-2 |
GO:0043923 | positive regulation by host of viral transcription | 1.897476e-2 |
GO:2000836 | positive regulation of androgen secretion | 1.926683e-2 |
GO:2000500 | positive regulation of induction of apoptosis in response to chemical stimulus | 1.926683e-2 |
GO:0021681 | cerebellar granular layer development | 1.933014e-2 |
GO:0042307 | positive regulation of protein import into nucleus | 1.943604e-2 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.966442e-2 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 1.966603e-2 |
GO:0034330 | cell junction organization | 1.966738e-2 |
GO:0060456 | positive regulation of digestive system process | 1.978633e-2 |
GO:0072329 | monocarboxylic acid catabolic process | 1.987286e-2 |
GO:0051301 | cell division | 1.996285e-2 |
GO:0072268 | pattern specification involved in metanephros development | 2.026069e-2 |
GO:0044264 | cellular polysaccharide metabolic process | 2.035197e-2 |
GO:0010559 | regulation of glycoprotein biosynthetic process | 2.039596e-2 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 2.070595e-2 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.071510e-2 |
GO:0042416 | dopamine biosynthetic process | 2.072395e-2 |
GO:0060510 | Type II pneumocyte differentiation | 2.079268e-2 |
GO:0070265 | necrotic cell death | 2.084741e-2 |
GO:0051702 | interaction with symbiont | 2.102449e-2 |
GO:0002158 | osteoclast proliferation | 2.127555e-2 |
GO:0006644 | phospholipid metabolic process | 2.157854e-2 |
GO:0070997 | neuron death | 2.174393e-2 |
GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process | 2.193916e-2 |
GO:0021895 | cerebral cortex neuron differentiation | 2.221520e-2 |
GO:0032740 | positive regulation of interleukin-17 production | 2.232134e-2 |
GO:0042053 | regulation of dopamine metabolic process | 2.232134e-2 |
GO:0032623 | interleukin-2 production | 2.232134e-2 |
GO:0048255 | mRNA stabilization | 2.232164e-2 |
GO:0070262 | peptidyl-serine dephosphorylation | 2.280817e-2 |
GO:0001824 | blastocyst development | 2.293552e-2 |
GO:0006497 | protein lipidation | 2.298588e-2 |
GO:0046886 | positive regulation of hormone biosynthetic process | 2.299052e-2 |
GO:0051494 | negative regulation of cytoskeleton organization | 2.328727e-2 |
GO:0042417 | dopamine metabolic process | 2.367310e-2 |
GO:0006376 | mRNA splice site selection | 2.390368e-2 |
GO:0042069 | regulation of catecholamine metabolic process | 2.391676e-2 |
GO:0006469 | negative regulation of protein kinase activity | 2.402152e-2 |
GO:0035814 | negative regulation of renal sodium excretion | 2.421467e-2 |
GO:0048193 | Golgi vesicle transport | 2.434172e-2 |
GO:0032321 | positive regulation of Rho GTPase activity | 2.443798e-2 |
GO:0021766 | hippocampus development | 2.448287e-2 |
GO:0060562 | epithelial tube morphogenesis | 2.466390e-2 |
GO:0031124 | mRNA 3'-end processing | 2.472043e-2 |
GO:0003283 | atrial septum development | 2.474278e-2 |
GO:0006626 | protein targeting to mitochondrion | 2.484681e-2 |
GO:0035809 | regulation of urine volume | 2.507114e-2 |
GO:0050954 | sensory perception of mechanical stimulus | 2.508215e-2 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 2.553956e-2 |
GO:0006105 | succinate metabolic process | 2.557951e-2 |
GO:0071844 | cellular component assembly at cellular level | 2.566234e-2 |
GO:0048145 | regulation of fibroblast proliferation | 2.585263e-2 |
GO:0021877 | forebrain neuron fate commitment | 2.600578e-2 |
GO:0090304 | nucleic acid metabolic process | 2.609226e-2 |
GO:0003161 | cardiac conduction system development | 2.643630e-2 |
GO:0071732 | cellular response to nitric oxide | 2.661274e-2 |
GO:0003266 | regulation of secondary heart field cardioblast proliferation | 2.661274e-2 |
GO:0060923 | cardiac muscle cell fate commitment | 2.665536e-2 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 2.675478e-2 |
GO:0006400 | tRNA modification | 2.687107e-2 |
GO:0019377 | glycolipid catabolic process | 2.687107e-2 |
GO:0003206 | cardiac chamber morphogenesis | 2.728141e-2 |
GO:0060343 | trabecula formation | 2.729541e-2 |
GO:0032317 | regulation of Rap GTPase activity | 2.744790e-2 |
GO:0031647 | regulation of protein stability | 2.759223e-2 |
GO:0006994 | positive regulation of transcription via sterol regulatory element binding involved in ER-nuclear sterol response pathway | 2.842854e-2 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 2.894488e-2 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 2.894488e-2 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 2.894488e-2 |
GO:0021983 | pituitary gland development | 2.895552e-2 |
GO:0006040 | amino sugar metabolic process | 2.912647e-2 |
GO:0046580 | negative regulation of Ras protein signal transduction | 2.952784e-2 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 2.978215e-2 |
GO:0061383 | trabecula morphogenesis | 2.990900e-2 |
GO:0006333 | chromatin assembly or disassembly | 3.009123e-2 |
GO:0035042 | fertilization, exchange of chromosomal proteins | 3.011809e-2 |
GO:0033157 | regulation of intracellular protein transport | 3.086087e-2 |
GO:0007281 | germ cell development | 3.091018e-2 |
GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep | 3.110316e-2 |
GO:0000050 | urea cycle | 3.110316e-2 |
GO:0003285 | septum secundum development | 3.130992e-2 |
GO:0034764 | positive regulation of transmembrane transport | 3.155053e-2 |
GO:0014832 | urinary bladder smooth muscle contraction | 3.245448e-2 |
GO:0007290 | spermatid nucleus elongation | 3.252011e-2 |
GO:0030185 | nitric oxide transport | 3.314147e-2 |
GO:0033058 | directional locomotion | 3.374843e-2 |
GO:0018345 | protein palmitoylation | 3.383599e-2 |
GO:0006991 | response to sterol depletion | 3.383599e-2 |
GO:0006342 | chromatin silencing | 3.384334e-2 |
GO:0006506 | GPI anchor biosynthetic process | 3.392886e-2 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 3.455136e-2 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 3.461072e-2 |
GO:0002698 | negative regulation of immune effector process | 3.487693e-2 |
GO:0051937 | catecholamine transport | 3.491846e-2 |
GO:0003278 | apoptosis involved in heart morphogenesis | 3.499461e-2 |
GO:0019627 | urea metabolic process | 3.524760e-2 |
GO:0009948 | anterior/posterior axis specification | 3.527918e-2 |
GO:0043046 | DNA methylation involved in gamete generation | 3.543070e-2 |
GO:0006730 | one-carbon metabolic process | 3.565094e-2 |
GO:0016311 | dephosphorylation | 3.578025e-2 |
GO:0006677 | glycosylceramide metabolic process | 3.594727e-2 |
GO:0042136 | neurotransmitter biosynthetic process | 3.594727e-2 |
GO:0006266 | DNA ligation | 3.596465e-2 |
GO:0018410 | C-terminal protein amino acid modification | 3.633485e-2 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 3.645351e-2 |
GO:0045988 | negative regulation of striated muscle contraction | 3.646817e-2 |
GO:0033197 | response to vitamin E | 3.646817e-2 |
GO:0030889 | negative regulation of B cell proliferation | 3.665980e-2 |
GO:0031936 | negative regulation of chromatin silencing | 3.668918e-2 |
GO:0040013 | negative regulation of locomotion | 3.695670e-2 |
GO:0014009 | glial cell proliferation | 3.699342e-2 |
GO:0001832 | blastocyst growth | 3.699342e-2 |
GO:0015793 | glycerol transport | 3.742117e-2 |
GO:0021819 | layer formation in cerebral cortex | 3.753961e-2 |
GO:0000281 | cytokinesis after mitosis | 3.753961e-2 |
GO:0034623 | cellular macromolecular complex disassembly | 3.783642e-2 |
GO:0016071 | mRNA metabolic process | 3.802631e-2 |
GO:0044242 | cellular lipid catabolic process | 3.803284e-2 |
GO:0034470 | ncRNA processing | 3.861396e-2 |
GO:0090073 | positive regulation of protein homodimerization activity | 3.890746e-2 |
GO:0071470 | cellular response to osmotic stress | 3.890746e-2 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 3.895243e-2 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 3.923249e-2 |
GO:0006781 | succinyl-CoA pathway | 3.957258e-2 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 3.966172e-2 |
GO:0043409 | negative regulation of MAPKKK cascade | 4.005497e-2 |
GO:0015760 | glucose-6-phosphate transport | 4.015317e-2 |
GO:0006435 | threonyl-tRNA aminoacylation | 4.015317e-2 |
GO:0043604 | amide biosynthetic process | 4.042338e-2 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 4.042338e-2 |
GO:0035910 | ascending aorta morphogenesis | 4.042338e-2 |
GO:0021515 | cell differentiation in spinal cord | 4.049719e-2 |
GO:0030148 | sphingolipid biosynthetic process | 4.066994e-2 |
GO:0021670 | lateral ventricle development | 4.135182e-2 |
GO:0060319 | primitive erythrocyte differentiation | 4.148507e-2 |
GO:0002575 | basophil chemotaxis | 4.148507e-2 |
GO:0021543 | pallium development | 4.174393e-2 |
GO:0051250 | negative regulation of lymphocyte activation | 4.189047e-2 |
GO:0071941 | nitrogen cycle metabolic process | 4.196878e-2 |
GO:0006657 | CDP-choline pathway | 4.196878e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0016926 | protein desumoylation | 3.995394e-12 |
GO:0006438 | valyl-tRNA aminoacylation | 1.050153e-9 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 4.920243e-8 |
GO:0009066 | aspartate family amino acid metabolic process | 8.879997e-8 |
GO:0043503 | skeletal muscle fiber adaptation | 1.014192e-7 |
GO:0060486 | Clara cell differentiation | 2.697244e-7 |
GO:0006739 | NADP metabolic process | 3.277681e-7 |
GO:0042696 | menarche | 5.035810e-7 |
GO:0021759 | globus pallidus development | 6.834323e-7 |
GO:0000096 | sulfur amino acid metabolic process | 9.823058e-7 |
GO:0071105 | response to interleukin-11 | 1.056633e-6 |
GO:0046364 | monosaccharide biosynthetic process | 1.575515e-6 |
GO:0060510 | Type II pneumocyte differentiation | 3.168286e-6 |
GO:0009086 | methionine biosynthetic process | 4.062188e-6 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 4.141517e-6 |
GO:0006555 | methionine metabolic process | 4.637247e-6 |
GO:0021953 | central nervous system neuron differentiation | 5.668832e-6 |
GO:0019362 | pyridine nucleotide metabolic process | 5.704497e-6 |
GO:0042538 | hyperosmotic salinity response | 6.772576e-6 |
GO:0019318 | hexose metabolic process | 1.191600e-5 |
GO:0071104 | response to interleukin-9 | 1.245688e-5 |
GO:0043500 | muscle adaptation | 1.626006e-5 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.724535e-5 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.788119e-5 |
GO:0043501 | skeletal muscle adaptation | 1.831528e-5 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 1.904505e-5 |
GO:0006566 | threonine metabolic process | 2.081056e-5 |
GO:0000097 | sulfur amino acid biosynthetic process | 2.231254e-5 |
GO:0070079 | histone H4-R3 demethylation | 2.267643e-5 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 2.267643e-5 |
GO:0070078 | histone H3-R2 demethylation | 2.267643e-5 |
GO:0019322 | pentose biosynthetic process | 2.930434e-5 |
GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.937518e-5 |
GO:0016070 | RNA metabolic process | 3.079496e-5 |
GO:0031128 | developmental induction | 4.012939e-5 |
GO:0046496 | nicotinamide nucleotide metabolic process | 4.516626e-5 |
GO:0034421 | post-translational protein acetylation | 4.640365e-5 |
GO:0006006 | glucose metabolic process | 5.183286e-5 |
GO:0030240 | skeletal muscle thin filament assembly | 5.413014e-5 |
GO:0043306 | positive regulation of mast cell degranulation | 5.680701e-5 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 5.680701e-5 |
GO:0022601 | menstrual cycle phase | 6.007921e-5 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 6.007921e-5 |
GO:0006366 | transcription from RNA polymerase II promoter | 6.567598e-5 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 6.726538e-5 |
GO:0009067 | aspartate family amino acid biosynthetic process | 7.415803e-5 |
GO:0043302 | positive regulation of leukocyte degranulation | 7.464593e-5 |
GO:0070995 | NADPH oxidation | 7.622371e-5 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 8.058015e-5 |
GO:0021954 | central nervous system neuron development | 8.413840e-5 |
GO:0090304 | nucleic acid metabolic process | 9.598501e-5 |
GO:0009448 | gamma-aminobutyric acid metabolic process | 1.052033e-4 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 1.071649e-4 |
GO:0005996 | monosaccharide metabolic process | 1.137078e-4 |
GO:0060492 | lung induction | 1.142266e-4 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 1.172997e-4 |
GO:0033005 | positive regulation of mast cell activation | 1.229943e-4 |
GO:0006972 | hyperosmotic response | 1.229943e-4 |
GO:0006564 | L-serine biosynthetic process | 1.316466e-4 |
GO:0014866 | skeletal myofibril assembly | 1.457030e-4 |
GO:0006007 | glucose catabolic process | 1.521249e-4 |
GO:0006098 | pentose-phosphate shunt | 1.607859e-4 |
GO:0048857 | neural nucleus development | 1.660787e-4 |
GO:0021877 | forebrain neuron fate commitment | 1.765293e-4 |
GO:0060487 | lung epithelial cell differentiation | 1.794486e-4 |
GO:0045647 | negative regulation of erythrocyte differentiation | 1.842992e-4 |
GO:0019320 | hexose catabolic process | 2.020757e-4 |
GO:0070262 | peptidyl-serine dephosphorylation | 2.228484e-4 |
GO:0070170 | regulation of tooth mineralization | 2.253590e-4 |
GO:0007525 | somatic muscle development | 2.253590e-4 |
GO:0007060 | male meiosis chromosome segregation | 2.264231e-4 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 2.264231e-4 |
GO:0060479 | lung cell differentiation | 2.294472e-4 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 2.365379e-4 |
GO:0044249 | cellular biosynthetic process | 2.452754e-4 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 2.482675e-4 |
GO:0019748 | secondary metabolic process | 2.553735e-4 |
GO:0046365 | monosaccharide catabolic process | 2.686195e-4 |
GO:0007021 | tubulin complex assembly | 2.704573e-4 |
GO:0014888 | striated muscle adaptation | 2.791060e-4 |
GO:0018126 | protein hydroxylation | 2.859260e-4 |
GO:0006352 | transcription initiation, DNA-dependent | 3.072915e-4 |
GO:0060430 | lung saccule development | 3.109149e-4 |
GO:0043491 | protein kinase B signaling cascade | 3.128732e-4 |
GO:0006790 | sulfur compound metabolic process | 3.258829e-4 |
GO:0019058 | viral infectious cycle | 3.594930e-4 |
GO:0016032 | viral reproduction | 3.952880e-4 |
GO:0019321 | pentose metabolic process | 4.113762e-4 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 4.336928e-4 |
GO:0034063 | stress granule assembly | 4.444289e-4 |
GO:0014853 | regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction | 4.650387e-4 |
GO:0070669 | response to interleukin-2 | 4.763791e-4 |
GO:0072668 | tubulin complex biogenesis | 4.918595e-4 |
GO:0034637 | cellular carbohydrate biosynthetic process | 5.206481e-4 |
GO:0046165 | alcohol biosynthetic process | 5.206481e-4 |
GO:0021750 | vestibular nucleus development | 5.221739e-4 |
GO:0021590 | cerebellum maturation | 5.221739e-4 |
GO:0021679 | cerebellar molecular layer development | 5.221739e-4 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 5.657059e-4 |
GO:0043304 | regulation of mast cell degranulation | 5.832959e-4 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 6.181001e-4 |
GO:0030011 | maintenance of cell polarity | 6.260369e-4 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.542272e-4 |
GO:0006563 | L-serine metabolic process | 6.556896e-4 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 6.638153e-4 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 6.761615e-4 |
GO:0009404 | toxin metabolic process | 6.863232e-4 |
GO:0007256 | activation of JNKK activity | 7.179557e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 7.670063e-4 |
GO:0019530 | taurine metabolic process | 7.842892e-4 |
GO:0002158 | osteoclast proliferation | 7.921999e-4 |
GO:0033006 | regulation of mast cell activation involved in immune response | 8.449242e-4 |
GO:0006351 | transcription, DNA-dependent | 8.934886e-4 |
GO:0021578 | hindbrain maturation | 9.225633e-4 |
GO:0032774 | RNA biosynthetic process | 9.287757e-4 |
GO:0006412 | translation | 1.000765e-3 |
GO:0010467 | gene expression | 1.022200e-3 |
GO:0019319 | hexose biosynthetic process | 1.022292e-3 |
GO:0042116 | macrophage activation | 1.092106e-3 |
GO:0006139 | nucleobase-containing compound metabolic process | 1.124193e-3 |
GO:0009651 | response to salt stress | 1.153610e-3 |
GO:0009059 | macromolecule biosynthetic process | 1.163059e-3 |
GO:0045646 | regulation of erythrocyte differentiation | 1.203163e-3 |
GO:0009058 | biosynthetic process | 1.233804e-3 |
GO:0060428 | lung epithelium development | 1.293562e-3 |
GO:0014056 | regulation of acetylcholine secretion | 1.301933e-3 |
GO:0009408 | response to heat | 1.338621e-3 |
GO:0006544 | glycine metabolic process | 1.374627e-3 |
GO:0051026 | chiasma assembly | 1.387882e-3 |
GO:0021522 | spinal cord motor neuron differentiation | 1.413711e-3 |
GO:0019307 | mannose biosynthetic process | 1.438712e-3 |
GO:0046543 | development of secondary female sexual characteristics | 1.500284e-3 |
GO:0016052 | carbohydrate catabolic process | 1.504639e-3 |
GO:0014819 | regulation of skeletal muscle contraction | 1.588116e-3 |
GO:0044275 | cellular carbohydrate catabolic process | 1.626424e-3 |
GO:0072229 | metanephric proximal convoluted tubule development | 1.694955e-3 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.694955e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 1.694955e-3 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 1.767008e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 1.823625e-3 |
GO:0060024 | rhythmic synaptic transmission | 2.089829e-3 |
GO:0021879 | forebrain neuron differentiation | 2.142892e-3 |
GO:0021895 | cerebral cortex neuron differentiation | 2.206289e-3 |
GO:0090007 | regulation of mitotic anaphase | 2.267367e-3 |
GO:0045047 | protein targeting to ER | 2.292145e-3 |
GO:0046164 | alcohol catabolic process | 2.328647e-3 |
GO:0033327 | Leydig cell differentiation | 2.469535e-3 |
GO:0008652 | cellular amino acid biosynthetic process | 2.486894e-3 |
GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis | 2.573943e-3 |
GO:2000791 | negative regulation of mesenchymal cell proliferation involved in lung development | 2.573943e-3 |
GO:0021740 | principal sensory nucleus of trigeminal nerve development | 2.573943e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 2.573943e-3 |
GO:0061141 | lung ciliated cell differentiation | 2.573943e-3 |
GO:0021956 | central nervous system interneuron axonogenesis | 2.583147e-3 |
GO:0022415 | viral reproductive process | 2.591722e-3 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.704849e-3 |
GO:0006090 | pyruvate metabolic process | 2.754686e-3 |
GO:0010001 | glial cell differentiation | 2.822008e-3 |
GO:0043654 | recognition of apoptotic cell | 2.839791e-3 |
GO:0010721 | negative regulation of cell development | 2.895279e-3 |
GO:0021510 | spinal cord development | 2.905053e-3 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 2.918385e-3 |
GO:0002003 | angiotensin maturation | 2.918385e-3 |
GO:0006493 | protein O-linked glycosylation | 2.937087e-3 |
GO:0009953 | dorsal/ventral pattern formation | 2.937341e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.978808e-3 |
GO:0000712 | resolution of meiotic recombination intermediates | 2.978808e-3 |
GO:0035640 | exploration behavior | 3.096238e-3 |
GO:0060578 | superior vena cava morphogenesis | 3.272890e-3 |
GO:0010226 | response to lithium ion | 3.274434e-3 |
GO:0043300 | regulation of leukocyte degranulation | 3.395901e-3 |
GO:0051307 | meiotic chromosome separation | 3.420696e-3 |
GO:0045136 | development of secondary sexual characteristics | 3.535933e-3 |
GO:0045132 | meiotic chromosome segregation | 3.562395e-3 |
GO:0051984 | positive regulation of chromosome segregation | 3.646473e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.674847e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 3.736363e-3 |
GO:0006107 | oxaloacetate metabolic process | 3.967966e-3 |
GO:0070171 | negative regulation of tooth mineralization | 4.038945e-3 |
GO:0006401 | RNA catabolic process | 4.772858e-3 |
GO:0030644 | cellular chloride ion homeostasis | 4.787598e-3 |
GO:0060460 | left lung morphogenesis | 4.879808e-3 |
GO:0001881 | receptor recycling | 4.879808e-3 |
GO:0060711 | labyrinthine layer development | 4.897084e-3 |
GO:0060712 | spongiotrophoblast layer development | 4.978348e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 5.241607e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 5.327830e-3 |
GO:0050886 | endocrine process | 5.334986e-3 |
GO:0044238 | primary metabolic process | 5.431516e-3 |
GO:0045686 | negative regulation of glial cell differentiation | 5.570107e-3 |
GO:0021517 | ventral spinal cord development | 5.616345e-3 |
GO:0065001 | specification of axis polarity | 5.794000e-3 |
GO:0009798 | axis specification | 5.806647e-3 |
GO:0021983 | pituitary gland development | 5.852001e-3 |
GO:0030320 | cellular monovalent inorganic anion homeostasis | 6.000513e-3 |
GO:0032353 | negative regulation of hormone biosynthetic process | 6.218822e-3 |
GO:0021871 | forebrain regionalization | 6.377972e-3 |
GO:0006477 | protein sulfation | 6.441818e-3 |
GO:0010043 | response to zinc ion | 6.445582e-3 |
GO:0009950 | dorsal/ventral axis specification | 6.486584e-3 |
GO:0043154 | negative regulation of caspase activity | 6.516560e-3 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 6.763245e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 6.780061e-3 |
GO:0060577 | pulmonary vein morphogenesis | 6.780061e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 6.780061e-3 |
GO:0015812 | gamma-aminobutyric acid transport | 6.901966e-3 |
GO:0030316 | osteoclast differentiation | 7.049142e-3 |
GO:0044260 | cellular macromolecule metabolic process | 7.251494e-3 |
GO:0021960 | anterior commissure morphogenesis | 7.381148e-3 |
GO:0006807 | nitrogen compound metabolic process | 7.551371e-3 |
GO:0000723 | telomere maintenance | 7.704536e-3 |
GO:0030324 | lung development | 7.790797e-3 |
GO:0035641 | locomotory exploration behavior | 7.879543e-3 |
GO:0043687 | post-translational protein modification | 7.879543e-3 |
GO:0042063 | gliogenesis | 7.998993e-3 |
GO:0022618 | ribonucleoprotein complex assembly | 8.118156e-3 |
GO:0030878 | thyroid gland development | 8.274808e-3 |
GO:0070670 | response to interleukin-4 | 8.377585e-3 |
GO:0030323 | respiratory tube development | 8.437051e-3 |
GO:0021872 | forebrain generation of neurons | 8.672792e-3 |
GO:0002074 | extraocular skeletal muscle development | 8.962055e-3 |
GO:0006824 | cobalt ion transport | 9.210664e-3 |
GO:0042481 | regulation of odontogenesis | 9.271529e-3 |
GO:0003209 | cardiac atrium morphogenesis | 9.365279e-3 |
GO:0032200 | telomere organization | 9.457457e-3 |
GO:0007283 | spermatogenesis | 9.522811e-3 |
GO:0032055 | negative regulation of translation in response to stress | 9.550249e-3 |
GO:0021623 | oculomotor nerve formation | 9.550249e-3 |
GO:0003404 | optic vesicle morphogenesis | 9.550249e-3 |
GO:0003409 | optic cup structural organization | 9.550249e-3 |
GO:0003073 | regulation of systemic arterial blood pressure | 9.600966e-3 |
GO:0001893 | maternal placenta development | 9.645793e-3 |
GO:0048713 | regulation of oligodendrocyte differentiation | 9.670260e-3 |
GO:0051923 | sulfation | 9.777561e-3 |
GO:0048791 | calcium ion-dependent exocytosis of neurotransmitter | 9.777561e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 9.785357e-3 |
GO:0006520 | cellular amino acid metabolic process | 9.890720e-3 |
GO:0071826 | ribonucleoprotein complex subunit organization | 1.004646e-2 |
GO:0071281 | cellular response to iron ion | 1.015517e-2 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.015517e-2 |
GO:0060509 | Type I pneumocyte differentiation | 1.036435e-2 |
GO:0048002 | antigen processing and presentation of peptide antigen | 1.064445e-2 |
GO:0016071 | mRNA metabolic process | 1.067428e-2 |
GO:0072014 | proximal tubule development | 1.077666e-2 |
GO:0071107 | response to parathyroid hormone stimulus | 1.097115e-2 |
GO:0034341 | response to interferon-gamma | 1.115673e-2 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 1.131394e-2 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 1.141453e-2 |
GO:0021548 | pons development | 1.159808e-2 |
GO:0007130 | synaptonemal complex assembly | 1.159808e-2 |
GO:0006094 | gluconeogenesis | 1.166404e-2 |
GO:0070172 | positive regulation of tooth mineralization | 1.206862e-2 |
GO:0002002 | regulation of angiotensin levels in blood | 1.206862e-2 |
GO:0071679 | commissural neuron axon guidance | 1.224525e-2 |
GO:0070972 | protein localization in endoplasmic reticulum | 1.254153e-2 |
GO:0044237 | cellular metabolic process | 1.274250e-2 |
GO:0000186 | activation of MAPKK activity | 1.294181e-2 |
GO:0003230 | cardiac atrium development | 1.302670e-2 |
GO:0021515 | cell differentiation in spinal cord | 1.302670e-2 |
GO:0006402 | mRNA catabolic process | 1.326936e-2 |
GO:0035993 | deltoid tuberosity development | 1.342480e-2 |
GO:0060541 | respiratory system development | 1.360556e-2 |
GO:0033003 | regulation of mast cell activation | 1.371590e-2 |
GO:0014014 | negative regulation of gliogenesis | 1.398156e-2 |
GO:0007527 | adult somatic muscle development | 1.412655e-2 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.412655e-2 |
GO:0006541 | glutamine metabolic process | 1.442039e-2 |
GO:0071559 | response to transforming growth factor beta stimulus | 1.444449e-2 |
GO:0060459 | left lung development | 1.484386e-2 |
GO:0060441 | epithelial tube branching involved in lung morphogenesis | 1.542869e-2 |
GO:0060317 | cardiac epithelial to mesenchymal transition | 1.578768e-2 |
GO:0042438 | melanin biosynthetic process | 1.578768e-2 |
GO:0045921 | positive regulation of exocytosis | 1.582779e-2 |
GO:0016051 | carbohydrate biosynthetic process | 1.643646e-2 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.655882e-2 |
GO:0007626 | locomotory behavior | 1.659234e-2 |
GO:0060425 | lung morphogenesis | 1.700829e-2 |
GO:0060177 | regulation of angiotensin metabolic process | 1.708749e-2 |
GO:0017157 | regulation of exocytosis | 1.708851e-2 |
GO:0044262 | cellular carbohydrate metabolic process | 1.769095e-2 |
GO:0033133 | positive regulation of glucokinase activity | 1.786540e-2 |
GO:0070257 | positive regulation of mucus secretion | 1.786540e-2 |
GO:0048741 | skeletal muscle fiber development | 1.853715e-2 |
GO:0031581 | hemidesmosome assembly | 1.857455e-2 |
GO:0043555 | regulation of translation in response to stress | 1.865807e-2 |
GO:0042262 | DNA protection | 1.885497e-2 |
GO:0006203 | dGTP catabolic process | 1.885497e-2 |
GO:0021536 | diencephalon development | 1.915865e-2 |
GO:0060088 | auditory receptor cell stereocilium organization | 1.941759e-2 |
GO:0071711 | basement membrane organization | 1.946533e-2 |
GO:0070193 | synaptonemal complex organization | 2.028148e-2 |
GO:0045650 | negative regulation of macrophage differentiation | 2.028703e-2 |
GO:2000027 | regulation of organ morphogenesis | 2.071974e-2 |
GO:0002093 | auditory receptor cell morphogenesis | 2.161642e-2 |
GO:0009069 | serine family amino acid metabolic process | 2.171566e-2 |
GO:0021603 | cranial nerve formation | 2.197314e-2 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 2.283724e-2 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 2.283724e-2 |
GO:0006970 | response to osmotic stress | 2.292828e-2 |
GO:0001890 | placenta development | 2.311172e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 2.448495e-2 |
GO:0006613 | cotranslational protein targeting to membrane | 2.460677e-2 |
GO:0008380 | RNA splicing | 2.487396e-2 |
GO:0044272 | sulfur compound biosynthetic process | 2.491005e-2 |
GO:0032288 | myelin assembly | 2.491386e-2 |
GO:0006582 | melanin metabolic process | 2.491386e-2 |
GO:0072201 | negative regulation of mesenchymal cell proliferation | 2.540578e-2 |
GO:0006066 | alcohol metabolic process | 2.559515e-2 |
GO:0007131 | reciprocal meiotic recombination | 2.590290e-2 |
GO:0070646 | protein modification by small protein removal | 2.594825e-2 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 2.652814e-2 |
GO:0002040 | sprouting angiogenesis | 2.668940e-2 |
GO:0045638 | negative regulation of myeloid cell differentiation | 2.699205e-2 |
GO:0072086 | specification of loop of Henle identity | 2.736216e-2 |
GO:0030002 | cellular anion homeostasis | 2.794339e-2 |
GO:0060716 | labyrinthine layer blood vessel development | 2.794339e-2 |
GO:0021506 | anterior neuropore closure | 2.926477e-2 |
GO:0021955 | central nervous system neuron axonogenesis | 2.931490e-2 |
GO:0006910 | phagocytosis, recognition | 3.006689e-2 |
GO:0021702 | cerebellar Purkinje cell differentiation | 3.006689e-2 |
GO:0045948 | positive regulation of translational initiation | 3.023534e-2 |
GO:0035810 | positive regulation of urine volume | 3.023534e-2 |
GO:0009309 | amine biosynthetic process | 3.062457e-2 |
GO:0071577 | zinc ion transmembrane transport | 3.115967e-2 |
GO:0017148 | negative regulation of translation | 3.126678e-2 |
GO:0044283 | small molecule biosynthetic process | 3.173457e-2 |
GO:0090076 | relaxation of skeletal muscle | 3.221432e-2 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 3.221432e-2 |
GO:0070255 | regulation of mucus secretion | 3.322244e-2 |
GO:0021782 | glial cell development | 3.341687e-2 |
GO:0007229 | integrin-mediated signaling pathway | 3.347855e-2 |
GO:0043648 | dicarboxylic acid metabolic process | 3.369214e-2 |
GO:0006732 | coenzyme metabolic process | 3.387054e-2 |
GO:0060117 | auditory receptor cell development | 3.398170e-2 |
GO:0005975 | carbohydrate metabolic process | 3.419228e-2 |
GO:0071361 | cellular response to ethanol | 3.424280e-2 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 3.480804e-2 |
GO:0006882 | cellular zinc ion homeostasis | 3.514639e-2 |
GO:0021557 | oculomotor nerve development | 3.527525e-2 |
GO:0003350 | pulmonary myocardium development | 3.527525e-2 |
GO:0007389 | pattern specification process | 3.560276e-2 |
GO:0060561 | apoptosis involved in morphogenesis | 3.573639e-2 |
GO:0051403 | stress-activated MAPK cascade | 3.631966e-2 |
GO:0045649 | regulation of macrophage differentiation | 3.631966e-2 |
GO:0033131 | regulation of glucokinase activity | 3.631966e-2 |
GO:0009266 | response to temperature stimulus | 3.672973e-2 |
GO:0021795 | cerebral cortex cell migration | 3.709202e-2 |
GO:0043170 | macromolecule metabolic process | 3.736569e-2 |
GO:0072081 | specification of nephron tubule identity | 3.737590e-2 |
GO:0006228 | UTP biosynthetic process | 3.737590e-2 |
GO:0006165 | nucleoside diphosphate phosphorylation | 3.737590e-2 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 3.814723e-2 |
GO:0007129 | synapsis | 3.876261e-2 |
GO:0055069 | zinc ion homeostasis | 3.876261e-2 |
GO:0001759 | organ induction | 3.938302e-2 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 3.952329e-2 |
GO:0006183 | GTP biosynthetic process | 3.952329e-2 |
GO:0016049 | cell growth | 4.055122e-2 |
GO:0070192 | chromosome organization involved in meiosis | 4.127444e-2 |
GO:0019882 | antigen processing and presentation | 4.200251e-2 |
GO:0006096 | glycolysis | 4.232107e-2 |
GO:0046835 | carbohydrate phosphorylation | 4.282971e-2 |
GO:0006241 | CTP biosynthetic process | 4.282971e-2 |
GO:0006000 | fructose metabolic process | 4.321086e-2 |
GO:0019752 | carboxylic acid metabolic process | 4.339400e-2 |
GO:0070050 | neuron homeostasis | 4.395407e-2 |
GO:0007635 | chemosensory behavior | 4.395407e-2 |
GO:0000245 | spliceosome assembly | 4.447902e-2 |
GO:0060122 | inner ear receptor stereocilium organization | 4.452667e-2 |
GO:0030148 | sphingolipid biosynthetic process | 4.459350e-2 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 4.484323e-2 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 4.623536e-2 |
GO:0060674 | placenta blood vessel development | 4.653740e-2 |
GO:0044106 | cellular amine metabolic process | 4.672196e-2 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 4.739203e-2 |
GO:0046467 | membrane lipid biosynthetic process | 4.796968e-2 |
GO:0032412 | regulation of ion transmembrane transporter activity | 4.965859e-2 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 5.069091e-2 |
GO:0001957 | intramembranous ossification | 5.069091e-2 |
GO:0007140 | male meiosis | 5.069091e-2 |
GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 5.092462e-2 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 5.092462e-2 |
GO:0048015 | phosphatidylinositol-mediated signaling | 5.092898e-2 |
GO:0042180 | cellular ketone metabolic process | 5.183413e-2 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.211413e-2 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 5.212259e-2 |
GO:0060973 | cell migration involved in heart development | 5.212259e-2 |
GO:0035910 | ascending aorta morphogenesis | 5.212259e-2 |
GO:0006620 | posttranslational protein targeting to membrane | 5.212259e-2 |
GO:0001892 | embryonic placenta development | 5.268556e-2 |
GO:0031060 | regulation of histone methylation | 5.283293e-2 |
GO:0048709 | oligodendrocyte differentiation | 5.314141e-2 |
GO:0046874 | quinolinate metabolic process | 5.333059e-2 |
GO:0022602 | ovulation cycle process | 5.477546e-2 |
GO:0007274 | neuromuscular synaptic transmission | 5.501795e-2 |
GO:2000491 | positive regulation of hepatic stellate cell activation | 5.550694e-2 |
GO:0021935 | cerebellar granule cell precursor tangential migration | 5.550694e-2 |
GO:0006426 | glycyl-tRNA aminoacylation | 5.550694e-2 |
GO:0051569 | regulation of histone H3-K4 methylation | 5.577614e-2 |
GO:0046784 | intronless viral mRNA export from host nucleus | 5.577614e-2 |
GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process | 5.577614e-2 |
GO:0006082 | organic acid metabolic process | 5.664556e-2 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 5.701346e-2 |
GO:0031109 | microtubule polymerization or depolymerization | 5.701346e-2 |
GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 5.701346e-2 |
GO:0050885 | neuromuscular process controlling balance | 5.711136e-2 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 5.951660e-2 |
GO:0002573 | myeloid leukocyte differentiation | 6.061314e-2 |
GO:0002281 | macrophage activation involved in immune response | 6.078217e-2 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 6.090773e-2 |
GO:0010715 | regulation of extracellular matrix disassembly | 6.205694e-2 |
GO:0061308 | cardiac neural crest cell development involved in heart development | 6.334077e-2 |
GO:0043137 | DNA replication, removal of RNA primer | 6.445435e-2 |
GO:0035809 | regulation of urine volume | 6.463356e-2 |
GO:0070509 | calcium ion import | 6.463356e-2 |
GO:0021559 | trigeminal nerve development | 6.463356e-2 |
GO:0070988 | demethylation | 6.495906e-2 |
GO:0061004 | pattern specification involved in kidney development | 6.593518e-2 |
GO:0021523 | somatic motor neuron differentiation | 6.593518e-2 |
GO:0006612 | protein targeting to membrane | 6.675387e-2 |
GO:0060174 | limb bud formation | 6.735783e-2 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 6.989200e-2 |
GO:0022898 | regulation of transmembrane transporter activity | 7.009840e-2 |
GO:0006413 | translational initiation | 7.092249e-2 |
GO:0006376 | mRNA splice site selection | 7.148058e-2 |
GO:0042147 | retrograde transport, endosome to Golgi | 7.148058e-2 |
GO:0021680 | cerebellar Purkinje cell layer development | 7.231392e-2 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 7.231392e-2 |
GO:0046394 | carboxylic acid biosynthetic process | 7.280418e-2 |
GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process | 7.331715e-2 |
GO:0006273 | lagging strand elongation | 7.331715e-2 |
GO:0021697 | cerebellar cortex formation | 7.399362e-2 |
GO:0006397 | mRNA processing | 7.436256e-2 |
GO:0048609 | multicellular organismal reproductive process | 7.526005e-2 |
GO:0009147 | pyrimidine nucleoside triphosphate metabolic process | 7.528479e-2 |
GO:0010464 | regulation of mesenchymal cell proliferation | 7.598876e-2 |
GO:0042698 | ovulation cycle | 7.632292e-2 |
GO:0014889 | muscle atrophy | 7.665316e-2 |
GO:0006281 | DNA repair | 7.691388e-2 |
GO:0030099 | myeloid cell differentiation | 7.772357e-2 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 7.802940e-2 |
GO:0002328 | pro-B cell differentiation | 7.802940e-2 |
GO:0010623 | developmental programmed cell death | 7.913566e-2 |
GO:0046826 | negative regulation of protein export from nucleus | 7.941338e-2 |
GO:0032908 | regulation of transforming growth factor beta1 production | 7.941338e-2 |
GO:0016577 | histone demethylation | 8.000748e-2 |
GO:0048845 | venous blood vessel morphogenesis | 8.080502e-2 |
GO:0035553 | oxidative single-stranded RNA demethylation | 8.209614e-2 |
GO:0060055 | angiogenesis involved in wound healing | 8.220420e-2 |
GO:0045685 | regulation of glial cell differentiation | 8.339961e-2 |
GO:0055081 | anion homeostasis | 8.353635e-2 |
GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 8.361082e-2 |
GO:0061303 | cornea development in camera-type eye | 8.361082e-2 |
GO:0006013 | mannose metabolic process | 8.361082e-2 |
GO:0007059 | chromosome segregation | 8.374605e-2 |
GO:0034498 | early endosome to Golgi transport | 8.645446e-2 |
GO:0019953 | sexual reproduction | 8.697831e-2 |
GO:0006482 | protein demethylation | 8.803953e-2 |
GO:0000413 | protein peptidyl-prolyl isomerization | 8.884689e-2 |
GO:0003289 | atrial septum primum morphogenesis | 8.930970e-2 |
GO:0048747 | muscle fiber development | 8.993714e-2 |
GO:0030168 | platelet activation | 9.024404e-2 |
GO:0009268 | response to pH | 9.078958e-2 |
GO:0001544 | initiation of primordial ovarian follicle growth | 9.079212e-2 |
GO:0006986 | response to unfolded protein | 9.110499e-2 |
GO:0043001 | Golgi to plasma membrane protein transport | 9.220118e-2 |
GO:0060215 | primitive hemopoiesis | 9.220118e-2 |
GO:0022029 | telencephalon cell migration | 9.227233e-2 |
GO:0007276 | gamete generation | 9.253601e-2 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 9.488669e-2 |
GO:0042245 | RNA repair | 9.510922e-2 |
GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 9.510922e-2 |
GO:0071636 | positive regulation of transforming growth factor beta production | 9.511964e-2 |
GO:0031061 | negative regulation of histone methylation | 9.658875e-2 |
GO:0043113 | receptor clustering | 9.666046e-2 |
GO:0006310 | DNA recombination | 9.703881e-2 |
GO:0045989 | positive regulation of striated muscle contraction | 9.806432e-2 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 9.806432e-2 |
GO:0072215 | regulation of metanephros development | 9.925009e-2 |
GO:0060697 | positive regulation of phospholipid catabolic process | 9.940586e-2 |
GO:0048485 | sympathetic nervous system development | 1.003152e-1 |
GO:0014031 | mesenchymal cell development | 1.026590e-1 |
GO:0060612 | adipose tissue development | 1.031087e-1 |
GO:0048266 | behavioral response to pain | 1.031087e-1 |
GO:0042133 | neurotransmitter metabolic process | 1.031087e-1 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 1.031087e-1 |
GO:0021885 | forebrain cell migration | 1.037416e-1 |
GO:0046939 | nucleotide phosphorylation | 1.040293e-1 |
GO:0060119 | inner ear receptor cell development | 1.040826e-1 |
GO:0008219 | cell death | 1.043775e-1 |
GO:0014002 | astrocyte development | 1.055358e-1 |
GO:0021952 | central nervous system projection neuron axonogenesis | 1.060412e-1 |
GO:0001954 | positive regulation of cell-matrix adhesion | 1.060412e-1 |
GO:0035249 | synaptic transmission, glutamatergic | 1.070259e-1 |
GO:0032467 | positive regulation of cytokinesis | 1.070481e-1 |
GO:0070946 | neutrophil mediated killing of gram-positive bacterium | 1.079381e-1 |
GO:0009253 | peptidoglycan catabolic process | 1.079381e-1 |
GO:0008152 | metabolic process | 1.082549e-1 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 1.094096e-1 |
GO:0043277 | apoptotic cell clearance | 1.100014e-1 |